Next Generation Sequencing Market is expected to grow at a CAGR of 13.48% during the forecasted period | Evolve Business Intelligence

Key Highlights:
• The global Next Generation Sequencing Market size was valued at USD 9.23 billion in 2022 growing at a CAGR of 13.48% from 2023 to 2033.
• North America dominated the market in 2022
• Asia Pacific is expected to grow at the highest CAGR from 2023 to 2033

As per the study initiated by Evolve Business Intelligence, the global Next Generation Sequencing Market size accounted for USD 9.23 billion in 2022, growing at a CAGR of 13.48% from 2023 to 2033.The Next Generation Sequencing (NGS) market involves advanced DNA sequencing technologies that enable rapid and cost-effective analysis of genetic material. It encompasses high-throughput sequencing methods used in research, clinical diagnostics, pharmaceuticals, and agriculture. Key players in this market include Illumina, Thermo Fisher Scientific, and Oxford Nanopore Technologies, driving innovation in sequencing platforms, data analysis software, and applications in personalized medicine, disease research, and agriculture. The market is poised for growth due to expanding applications, decreasing sequencing costs, and increasing demand for precision medicine solutions.

Request/Download PDF Sample: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021388

The Next Generation Sequencing (NGS) market is primarily propelled by technological advancements enhancing sequencing speed, accuracy, and cost-efficiency. Increasing applications in clinical diagnostics, personalized medicine, and research drive its growth. Additionally, rising demand for genomic insights in areas like oncology, infectious diseases, and agriculture further fuels the market expansion.

Key Players
Some of the major Next Generation Sequencing Market players holding high market shares include Illumina; QIAGEN; Thermo Fisher Scientific, Inc.; F. Hoffman-La Roche Ltd.. These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders. Some of the other major market players include Oxford Nanopore Technologies; Genomatix GmbH; PierianDx; DNASTAR, Inc.; Eurofins GATC Biotech GmbH; Perkin Elmer, Inc.; BGI; Bio-Rad Laboratories, Inc.

For More Information: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021388

Segmental Analysis
Based on Technology, the Next Generation Sequencing market is segmented into WGS, Whole Exome Sequencing and Targeted Sequencing & Resequencing. With a market share of 73.67% in 2023, the targeted sequencing and resequencing category had the largest share. The demand for this market is anticipated to increase as whole genome sequencing becomes more popular since it will be necessary to have access to a substantial amount of whole genome data in order to isolate genetic expressions and examine certain gene locations.
Based on Product, the Next Generation Sequencing market is segmented into Platform and Consumables. With a 75.15% market share in 2023, the consumables category is expected to grow at the quickest rate between 2024 and 2030. The greater share and exponential growth rate of this market are mostly attributable to the frequent use and strong demand for consumables in both NGS research and commercial applications.
Based on Application, the Next Generation Sequencing market is segmented into Oncology, Clinical Investigation, Reproductive Health, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Agrigenomics & Forensics and Consumer Genomics. In 2023, the oncology category had the most market share, accounting for 27.31%. The high market share can be attributed to a number of factors, including the steadily rising incidence of cancer, which calls for the use of cutting-edge technology to help oncologists better understand the mechanics of cancer and tumor cells, and the use of NGS for DNA and RNA sequencing, epigenetics, and chromosomal abnormality analysis, which accounts for more than three-quarters of all global sequencing data.
Based onWorkflow, the Next Generation Sequencing market is segmented into Pre-Sequencing, Sequencing and NGS Data Analysis. In 2023, the sequencing sector had the highest market share, with 57.15%. NGS sequencing holds the biggest market share since it is the most crucial stage of the workflow. The ability of these technologies to deliver a precise liquid amount is crucial for NGS.

Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, BeNeLux, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Rest of Asia Pacific)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)
• Latin America (Mexico, Brazil, Argentina, Rest of Latin America)

Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/

Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune's global 2000 companies.

This release was published on openPR.